Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP754261.RAVzJAguxwYviGdctov7lPyCZNXdCFfJko3l4gv4pNNr0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP754261.RAVzJAguxwYviGdctov7lPyCZNXdCFfJko3l4gv4pNNr0130_assertion type Assertion NP754261.RAVzJAguxwYviGdctov7lPyCZNXdCFfJko3l4gv4pNNr0130_head.
- NP754261.RAVzJAguxwYviGdctov7lPyCZNXdCFfJko3l4gv4pNNr0130_assertion description "[Collectively, these results provide important new insight into the pathogenesis of NK-cell lymphoma/leukemia and suggest targeting miR-21 and/or miR-155 may represent a useful approach to treating NK-cell lymphoma/leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754261.RAVzJAguxwYviGdctov7lPyCZNXdCFfJko3l4gv4pNNr0130_provenance.
- NP754261.RAVzJAguxwYviGdctov7lPyCZNXdCFfJko3l4gv4pNNr0130_assertion evidence source_evidence_literature NP754261.RAVzJAguxwYviGdctov7lPyCZNXdCFfJko3l4gv4pNNr0130_provenance.
- NP754261.RAVzJAguxwYviGdctov7lPyCZNXdCFfJko3l4gv4pNNr0130_assertion SIO_000772 19641183 NP754261.RAVzJAguxwYviGdctov7lPyCZNXdCFfJko3l4gv4pNNr0130_provenance.
- NP754261.RAVzJAguxwYviGdctov7lPyCZNXdCFfJko3l4gv4pNNr0130_assertion wasDerivedFrom befree-2016 NP754261.RAVzJAguxwYviGdctov7lPyCZNXdCFfJko3l4gv4pNNr0130_provenance.
- NP754261.RAVzJAguxwYviGdctov7lPyCZNXdCFfJko3l4gv4pNNr0130_assertion wasGeneratedBy ECO_0000203 NP754261.RAVzJAguxwYviGdctov7lPyCZNXdCFfJko3l4gv4pNNr0130_provenance.